Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News

October
12

EANO 2016

Read Full Story

October
22

18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story

November
16

2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

WFNOS Magazine

 

The Society for Neuro-Oncology (SNO)
and the European Association of Neuro-Oncology (EANO)
have the pleasure to announce the publication of the first issue of the
World Federation of Neuro-Oncology Societies (WFNOS) Magazine

This new magazine is a transition from the EANO magazine and pursues the mission
to become a central platform for communication for all those interested in neuro-oncology,
including professionals involved in the diagnosis and care of brain tumor patients across the world.

 

 WFNO_Magazine.png

 

Table of Contents

  • NSCLC Cell Adhesion to and Transmigration through Brain Endothelium in Brain Metastasis
  • Prevention of Brain Metastasis by Inhibition of Angiogenesis?
  • Glioblastoma: Example of Translational Research in Radiotherapy and Radiobiology
  • Development of a Questionnaire to Measure Instrumental Activities of Daily Living (IADL) in Patients with Brain Tumors
  • A pro/con debate on the first-line treatment of patients with high-grade gliomas: An interview with Roger Stupp and Michael Prados
  • Indian Society of Neuro-Oncology: Challenges and Opportunities
  • Nurses Corner
  • Brain Tumor Patient Advocacy—Who Needs It?
  • Targeting IDH1R132H in WHO grade III and IV IDH1R132H-mutated gliomas by a peptide vaccine: a first-in-man phase I safety, tolerability, and immunogenicity multicenter trial (NOA-16)
  • Hotspots in Neuro-Oncology 2016

To view the entire Volume 1 (2016) Issue 1, please click here (pdf)